{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T10:50:02Z","timestamp":1770115802338,"version":"3.49.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research Bulletin"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.brainresbull.2012.10.011","type":"journal-article","created":{"date-parts":[[2012,11,10]],"date-time":"2012-11-10T16:31:50Z","timestamp":1352565110000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["\u03b2CCT, an antagonist selective for \u03b11GABAA receptors, reverses diazepam withdrawal-induced anxiety in rats"],"prefix":"10.1016","volume":"91","author":[{"given":"Jovana","family":"Divljakovi\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marija","family":"Mili\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ojas A.","family":"Namjoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veera V.","family":"Tiruveedhula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Timi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miroslav M.","family":"Savi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainresbull.2012.10.011_bib0005","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1046\/j.1471-4159.2001.00664.x","article-title":"Chronic benzodiazepine treatment of cells expressing recombinant GABA(A) receptors uncouples allosteric binding: studies on possible mechanisms","volume":"79","author":"Ali","year":"2001","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.brainresbull.2012.10.011_bib0010","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0163-7258(03)00029-9","article-title":"Neuroadaptive processes in GABAergic and glutamatergic systems in benzodiazepine dependence","volume":"98","author":"Allison","year":"2003","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.brainresbull.2012.10.011_bib0015","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1124\/jpet.109.158303","article-title":"Reducing abuse liability of GABAA\/benzodiazepine ligands via selective partial agonist efficacy at alpha1 and alpha2\/3 subtypes","volume":"332","author":"Ator","year":"2010","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.brainresbull.2012.10.011_bib0020","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/1381612023396681","article-title":"Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal","volume":"8","author":"Bateson","year":"2002","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.brainresbull.2012.10.011_bib0025","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00008877-200004000-00004","article-title":"Beta-CCT a selective BZ-omega1 receptor antagonist, blocks the anti-anxiety but not the amnesic action of chlordiazepoxide in mice","volume":"11","author":"Belzung","year":"2000","journal-title":"Behavioural Pharmacology"},{"key":"10.1016\/j.brainresbull.2012.10.011_bib0030","first-page":"12A","article-title":"The role of the GABA A1 subunit in mediating the sedative and anxiolytic properties of benzodiazepines","volume":"25","author":"Carroll","year":"2001","journal-title":"Alcoholism, Clinical and Experimental Research"},{"key":"10.1016\/j.brainresbull.2012.10.011_bib0035","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0091-3057(94)90472-3","article-title":"Ethopharmacological analysis of rat behavior on the elevated plus-maze","volume":"49","author":"Cruz","year":"1994","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.brainresbull.2012.10.011_bib0040","first-page":"710","article-title":"Bz1 receptor subtype specific ligands: synthesis and biological properties of \u03b2CCt, a Bz1 receptor subtype specific antagonist","volume":"5","author":"Cox","year":"1995","journal-title":"Medicinal Chemistry Research"},{"key":"10.1016\/j.brainresbull.2012.10.011_bib0180","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0165-6147(00)88973-7","article-title":"Use of the elevated plus maze in the search for novel anxiolytic agents","volume":"16","author":"Dawson","year":"1995","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.brainresbull.2012.10.011_bib0185","doi-asserted-by":"crossref","unstructured":"Dell\u2019osso, B., Lader, M., 2012. Do benzodiazepines still deserve a major role in the treatment of psychiatric disorders? A critical reappraisal. European Psychiatry, http:\/\/dx.doi.org\/10.1016\/j.eurpsy.2011.11.003,psy.2011.11.003.","DOI":"10.1016\/j.eurpsy.2011.11.003"},{"key":"10.1016\/j.brainresbull.2012.10.011_bib0045","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/npp.2010.246","article-title":"Dopamine D3-like receptors modulate anxiety-like behavior and regulate GABAergic transmission in the rat lateral\/basolateral amygdala","volume":"36","author":"Diaz","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainresbull.2012.10.011_bib0050","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0278-5846(90)90029-G","article-title":"Effects of placebo (saline) injections on core temperature in the rat","volume":"14","author":"Dilsaver","year":"1990","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.brainresbull.2012.10.011_bib0055","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1177\/0269881109106954","article-title":"Social separation and diazepam withdrawal increase anxiety in the elevated plus-maze and serotonin turnover in the median raphe and hippocampus","volume":"24","author":"dos Santos","year":"2010","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.brainresbull.2012.10.011_bib0060","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/308074a0","article-title":"Chronic benzodiazepine treatment decreases postsynaptic GABA sensitivity","volume":"308","author":"Gallager","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.brainresbull.2012.10.011_bib0065","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/BF02244384","article-title":"Low but not high doses of buspirone reduce the anxiogenic effects of diazepam withdrawal","volume":"105","author":"File","year":"1991","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainresbull.2012.10.011_bib0070","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0361-9230(87)90079-7","article-title":"Anxiogenic effects in benzodiazepine withdrawal are linked to the development of tolerance","volume":"19","author":"File","year":"1987","journal-title":"Brain Research Bulletin"},{"key":"10.1016\/j.brainresbull.2012.10.011_bib0075","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/BF02244232","article-title":"A theory of benzodiazepine dependence that can explain whether flumazenil will enhance or reverse the phenomena","volume":"101","author":"File","year":"1990","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainresbull.2012.10.011_bib0080","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/npp.2008.89","article-title":"Long-lasting modulation of glutamatergic transmission in VTA dopamine neurons after a single dose of benzodiazepine agonists","volume":"34","author":"Heikkinen","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainresbull.2012.10.011_bib0085","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s002130051108","article-title":"New evidence that the pharmacological effects of benzodiazepine receptor ligands can be associated with activities at different BZ (omega) receptor subtypes","volume":"146","author":"Griebel","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainresbull.2012.10.011_bib0090","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1527-3458.2003.tb00241.x","article-title":"SL651498, a GABAA receptor agonist with subtype-selective efficacy, as a potential treatment for generalized anxiety disorder and muscle spasms","volume":"9","author":"Griebel","year":"2003","journal-title":"CNS Drug Reviews"},{"key":"10.1016\/j.brainresbull.2012.10.011_bib0095","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/0269881108100322","article-title":"The role of flumazenil in the treatment of benzodiazepine dependence: physiological and psychological profiles","volume":"23","author":"Hood","year":"2009","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.brainresbull.2012.10.011_bib0100","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0026-895X(25)10146-6","article-title":"Chronic benzodiazepine agonist treatment produces functional uncoupling of the gamma-aminobutyric acid-benzodiazepine receptor ionophore complex in cortical neurons","volume":"45","author":"Hu","year":"1994","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.brainresbull.2012.10.011_bib0105","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0026-895X(25)09071-6","article-title":"Modifications of gamma-aminobutyric acidA receptor subunit expression in rat neocortex during tolerance to diazepam","volume":"49","author":"Impagnatiello","year":"1996","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.brainresbull.2012.10.011_bib0110","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/01.fbp.0000082131.08343.0e","article-title":"Physical dependence in baboons chronically treated with low and high doses of diazepam","volume":"14","author":"Kaminski","year":"2003","journal-title":"Behavioural Pharmacology"},{"key":"10.1016\/j.brainresbull.2012.10.011_bib0115","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/npp.2009.110","article-title":"Neurocircuitry of addiction","volume":"35","author":"Koob","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainresbull.2012.10.011_bib0120","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pbb.2008.01.001","article-title":"Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond","volume":"90","author":"Licata","year":"2008","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.brainresbull.2012.10.011_bib0125","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/cne.20101","article-title":"Parvalbumin-containing interneurons in the basolateral amygdala express high levels of the alpha1 subunit of the GABAA receptor","volume":"473","author":"McDonald","year":"2004","journal-title":"Journal of Comparative Neurology"},{"key":"10.1016\/j.brainresbull.2012.10.011_bib0130","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1258\/002367706778476370","article-title":"Effect of restraint and injection methods on heart rate and body temperature in mice","volume":"40","author":"Meijer","year":"2006","journal-title":"Laboratory Animals"},{"key":"10.1016\/j.brainresbull.2012.10.011_bib0135","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s002130051161","article-title":"A controlled study of flumazenil-precipitated withdrawal in chronic low-dose benzodiazepine users","volume":"147","author":"Mintzer","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainresbull.2012.10.011_bib0140","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1124\/jpet.105.094474","article-title":"Do subtype-selective gamma-aminobutyric acid A receptor modulators have a reduced propensity to induce physical dependence in mice?","volume":"316","author":"Mirza","year":"2006","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.brainresbull.2012.10.011_bib0145","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0091-3057(95)00138-M","article-title":"Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety","volume":"52","author":"Rodgers","year":"1995","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.brainresbull.2012.10.011_bib0150","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.pnpbp.2010.01.004","article-title":"Novel positive allosteric modulators of GABAA receptors: do subtle differences in activity at alpha1 plus alpha5 versus alpha2 plus alpha3 subunits account for dissimilarities in behavioral effects in rats?","volume":"34","author":"Savi\u0107","year":"2010","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.brainresbull.2012.10.011_bib0155","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.pbb.2004.07.013","article-title":"Bidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze: differential antagonism by flumazenil and beta-CCt","volume":"79","author":"Savi\u0107","year":"2004","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.brainresbull.2012.10.011_bib0160","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.neuropharm.2011.07.026","article-title":"Anxiety and depression: mouse genetics and pharmacological approaches to the role of GABA(A) receptor subtypes","volume":"62","author":"Smith","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainresbull.2012.10.011_bib0165","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nature08758","article-title":"Neural bases for addictive properties of benzodiazepines","volume":"463","author":"Tan","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.brainresbull.2012.10.011_bib0190","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0022-3565(24)35193-6","article-title":"Antagonist-induced reversal of functional and structural measures of hippocampal benzodiazepine tolerance","volume":"291","author":"Tietz","year":"1999","journal-title":"The Journal of pharmacology and experimental therapeutics"},{"key":"10.1016\/j.brainresbull.2012.10.011_bib0170","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1124\/pr.109.002063","article-title":"Regulation of GABA(A) receptor subunit expression by pharmacological agents","volume":"62","author":"Uusi-Oukari","year":"2010","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.brainresbull.2012.10.011_bib0175","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1523\/JNEUROSCI.1067-04.2004","article-title":"Requirement of alpha5-GABAA receptors for the development of tolerance to the sedative action of diazepam in mice","volume":"24","author":"van Rijnsoever","year":"2004","journal-title":"Journal of Neuroscience"}],"container-title":["Brain Research Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923012002377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923012002377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T20:15:46Z","timestamp":1759781746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0361923012002377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":38,"alternative-id":["S0361923012002377"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresbull.2012.10.011","relation":{},"ISSN":["0361-9230"],"issn-type":[{"value":"0361-9230","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b2CCT, an antagonist selective for \u03b11GABAA receptors, reverses diazepam withdrawal-induced anxiety in rats","name":"articletitle","label":"Article Title"},{"value":"Brain Research Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainresbull.2012.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}